These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 10805111)
1. Scintigraphic detection of acute experimental endocarditis with the technetium-99m labelled glycoprotein IIb/IIIa receptor antagonist DMP444. Oyen WJ; Boerman OC; Brouwers FM; Barrett JA; Verheugt FW; Ruiter DJ; Corstens FH; van der Meer JW Eur J Nucl Med; 2000 Apr; 27(4):392-9. PubMed ID: 10805111 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of Tc-99m-labeled glycoprotein IIb/IIIa receptor antagonist DMP444 SPECT in patients with infective endocarditis. Brouwers FM; Oyen WJ; Boerman OC; Barrett JA; Verheugt FW; Corstens FH; Van der Meer JW Clin Nucl Med; 2003 Jun; 28(6):480-4. PubMed ID: 12911097 [TBL] [Abstract][Full Text] [Related]
3. Assessment of prosthetic vascular graft thrombogenicity using the technetium-99m labeled glycoprotein IIb/IIIa receptor antagonist DMP444 in a dog model. Scharn DM; Oyen WJ; Klemm PL; Wijnen MH; vanderVliet JA Cardiovasc Surg; 2002 Dec; 10(6):566-9. PubMed ID: 12453688 [TBL] [Abstract][Full Text] [Related]
4. Technetium 99m-labeled annexin V scintigraphy of platelet activation in vegetations of experimental endocarditis. Rouzet F; Dominguez Hernandez M; Hervatin F; Sarda-Mantel L; Lefort A; Duval X; Louedec L; Fantin B; Le Guludec D; Michel JB Circulation; 2008 Feb; 117(6):781-9. PubMed ID: 18227388 [TBL] [Abstract][Full Text] [Related]
5. New and versatile ternary ligand system for technetium radiopharmaceuticals: water soluble phosphines and tricine as coligands in labeling a hydrazinonicotinamide-modified cyclic glycoprotein IIb/IIIa receptor antagonist with 99mTc. Edwards DS; Liu S; Barrett JA; Harris AR; Looby RJ; Ziegler MC; Heminway SJ; Carroll TR Bioconjug Chem; 1997; 8(2):146-54. PubMed ID: 9095354 [TBL] [Abstract][Full Text] [Related]
6. Detection of deep venous thrombosis by DMP 444, a platelet IIb/IIIa antagonist: a preliminary report. Klem JA; Schaffer JV; Crane PD; Barrett JA; Henry GA; Canestri L; Ezekowitz MD J Nucl Cardiol; 2000; 7(4):359-64. PubMed ID: 10958278 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of 99mTc-labeled cyclic RGD peptide with a PEG4 linker for thrombosis imaging: comparison with DMP444. Fang W; He J; Kim YS; Zhou Y; Liu S Bioconjug Chem; 2011 Aug; 22(8):1715-22. PubMed ID: 21780818 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of 99mTc-UBI 29-41 scintigraphy for specific detection of experimental multidrug-resistant Staphylococcus aureus bacterial endocarditis. Brouwer CP; Gemmel FF; Welling MM Q J Nucl Med Mol Imaging; 2010 Aug; 54(4):442-50. PubMed ID: 20823811 [TBL] [Abstract][Full Text] [Related]
17. Thrombus imaging using technetium-99m-labeled high-potency GPIIb/IIIa receptor antagonists. Chemistry and initial biological studies. Pearson DA; Lister-James ; McBride WJ; Wilson DM; Martel LJ; Civitello ER; Dean RT J Med Chem; 1996 Mar; 39(7):1372-82. PubMed ID: 8691467 [TBL] [Abstract][Full Text] [Related]
18. Scintigraphic imaging of bacterial and fungal infection in granulocytopenic rats. Dams ET; Becker MJ; Oyen WJ; Boerman OC; Storm G; Laverman P; de Marie S; van der Meer JW; Bakker-Woudenberg IA; Corstens FH J Nucl Med; 1999 Dec; 40(12):2066-72. PubMed ID: 10616887 [TBL] [Abstract][Full Text] [Related]
19. Identification of low molecular weight GP IIb/IIIa antagonists that bind preferentially to activated platelets. Bednar RA; Gaul SL; Hamill TG; Egbertson MS; Shafer JA; Hartman GD; Gould RJ; Bednar B J Pharmacol Exp Ther; 1998 Jun; 285(3):1317-26. PubMed ID: 9618439 [TBL] [Abstract][Full Text] [Related]
20. Blockade of glycoprotein IIb/IIIa by crotavirin, a member of disintegrins, prevents platelet from activation and aggregation by Staphylococcus aureus bacteria. Liu CZ; Huang HY; Tsai PJ; Shih MH Thromb Res; 2005; 116(2):145-55. PubMed ID: 15907530 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]